Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Shares Outstanding (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Shares Outstanding for 6 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding fell 88.07% to $4.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Dec 2025, down 88.07% year-over-year, with the annual reading at $4.5 million for FY2025, 88.07% down from the prior year.
  • Shares Outstanding hit $4.5 million in Q4 2025 for Rapid Micro Biosystems, down from $39.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $6.9 billion in Q3 2021 to a low of $4.5 million in Q4 2025.
  • Historically, Shares Outstanding has averaged $729.3 million across 5 years, with a median of $37.1 million in 2023.
  • Biggest five-year swings in Shares Outstanding: soared 1925716.75% in 2021 and later tumbled 99.47% in 2022.
  • Year by year, Shares Outstanding stood at $34.6 million in 2021, then increased by 5.71% to $36.5 million in 2022, then increased by 1.54% to $37.1 million in 2023, then rose by 1.7% to $37.7 million in 2024, then tumbled by 88.07% to $4.5 million in 2025.
  • Business Quant data shows Shares Outstanding for RPID at $4.5 million in Q4 2025, $39.8 million in Q3 2025, and $39.6 million in Q2 2025.